PALVELLA THERAPEUTICS INC (PVLA) Stock Earnings Estimates
NASDAQ:PVLA • US6979471090
128.6 USD
+8.19 (+6.8%)
At close: Feb 25, 2026
129.83 USD
+1.23 (+0.96%)
After Hours: 2/25/2026, 4:30:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.418M 7.14% | 25.902M -17.56% | 42.81M 65.28% | 15.004K -100.00% | 27.203K | 13.767M 50,507.64% | 88.593M 543.52% | 258.37M 191.64% | 569.38M 120.37% | 872.68M 53.27% | 1.019B 16.77% | 1.306B 28.16% | ||
| EBITDA YoY % growth | -49.372M -56.19% | -40.704M 17.56% | -13.94M 65.75% | -15.463M -10.93% | -38.792M -150.86% | -51.756M -33.42% | -97.97M -89.29% | -46.528M 52.51% | 94.106M 302.26% | 384.61M 308.70% | 694.83M 80.66% | 1.077B 55.00% | 1.549B 43.83% | |
| EBIT YoY % growth | -51.831M -52.80% | -43.474M 16.12% | -15.844M 63.56% | -16.733M 11.64% | -38.855M -177.53% | -45.557M -17.25% | -80.707M -77.16% | -54.129M 32.93% | 77.34M 242.88% | 332.34M 329.71% | 553.99M 66.69% | 632.17M 14.11% | 861.76M 36.32% | |
| Operating Margin | -164.97% | -167.84% | -37.01% | -111,524.13% | N/A | -167,467.34% | -586.23% | -61.10% | 29.93% | 58.37% | 63.48% | 62.04% | 65.98% | |
| EPS YoY % growth | -55.37 -1.79% | -36.00 34.99% | N/A 99.01% | -3.06 -758.09% | -3.59 -17.14% | -4.04 -12.54% | -5.70 -41.11% | -3.16 44.54% | 4.72 249.31% | 19.96 322.93% | 29.43 47.47% | 27.75 -5.71% | 36.41 31.21% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.93 65.80% | -0.93 -25.43% | -0.94 -9.83% | -1.08 -4.87% | -1.22 -31.60% | -1.23 -32.97% | -1.51 -59.83% | -1.74 -61.47% | -0.87 29.17% |
| Revenue Q2Q % growth | 20.4K | 22.664K | -100.00% | 18.569M 81,830.25% | |||||
| EBITDA Q2Q % growth | -10.948M -97.62% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.939M -639.11% | -8.434M -7.15% | -9.259M -0.09% | -10.377M -1.97% | -16.631M -52.03% | -17.85M -111.65% | -21.42M -131.35% | -24.48M -135.90% | -12.685M 23.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.03 -1,919.61% | -0.86 | -0.17 | -20.45% |
| Q2 2025 Q2Q % growth | -0.86 -2,710.46% | -0.76 | -0.10 | -13.81% |
| Q1 2025 Q2Q % growth | -0.74 -1,109.15% | -1.24 | 0.50 | 40.10% |
| Q4 2024 Q2Q % growth | -2.72 -2,122.22% | -0.66 | -2.06 | -313.44% |
| Q3 2024 Q2Q % growth | -101.59% | -0.05 | % | |
| Q2 2024 Q2Q % growth | -100.76% | -0.03 | % | |
| Q1 2024 Q2Q % growth | 99.58% | -0.06 | % | |
| Q4 2023 Q2Q % growth | 98.61% | -0.12 | % | |
| Q3 2023 Q2Q % growth | 3.20 130.77% | -8.98 | 12.18 | 135.65% |
| Q2 2023 Q2Q % growth | 4.00 135.71% | -13.06 | 17.06 | 130.64% |
| Q1 2023 Q2Q % growth | -14.40 -157.14% | -11.42 | -2.98 | -26.05% |
| Q4 2022 Q2Q % growth | -8.80 16.76% | -18.77 | 9.97 | 53.11% |
| Q3 2022 Q2Q % growth | -10.40 45.83% | -13.06 | 2.66 | 20.34% |
| Q2 2022 Q2Q % growth | -11.20 44.00% | -8.98 | -2.22 | -24.78% |
| Q1 2022 Q2Q % growth | -5.60 | -9.38 | 3.78 | 40.32% |
| Q4 2021 Q2Q % growth | -10.57 49.17% | -24.48 | 13.91 | 56.81% |
| Q3 2021 Q2Q % growth | -19.20 7.69% | -19.86 | 0.66 | 3.30% |
| Q2 2021 Q2Q % growth | -20.00 -177.78% | -21.62 | 1.62 | 7.51% |
| Q1 2021 Q2Q % growth | -5.60 | -13.87 | 8.27 | 59.63% |
| Q4 2020 Q2Q % growth | -20.80 | -19.31 | -1.49 | -7.70% |
| Q3 2020 Q2Q % growth | -20.80 | -10.62 | -10.18 | -95.78% |
| Q2 2020 Q2Q % growth | -7.20 | -14.00 | 6.80 | 48.58% |
| Q1 2020 Q2Q % growth | -5.60 | -13.55 | 7.95 | 58.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | 1.09M | -1.09M | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 2.289M | -2.289M | -100.00% |
| Q1 2024 Q2Q % growth | 53K -97.26% | 2.289M | -2.236M | -97.68% |
| Q4 2023 Q2Q % growth | 1.299M -77.78% | 2.289M | -990K | -43.25% |
| Q3 2023 Q2Q % growth | 19.52M 263.50% | 7.899M | 11.621M | 147.12% |
| Q2 2023 Q2Q % growth | 20.055M 442.32% | 4.099M | 15.956M | 389.27% |
| Q1 2023 Q2Q % growth | 1.936M -82.38% | 6.636M | -4.7M | -70.83% |
| Q4 2022 Q2Q % growth | 5.846M -30.76% | 6.641M | -795K | -11.97% |
| Q3 2022 Q2Q % growth | 5.37M 32.36% | 2.301M | 3.069M | 133.38% |
| Q2 2022 Q2Q % growth | 3.698M 12.57% | 10.68M | -6.982M | -65.37% |
| Q1 2022 Q2Q % growth | 10.988M -29.71% | 11.53M | -542K | -4.70% |
| Q4 2021 Q2Q % growth | 8.443M 349.81% | 2.503M | 5.94M | 237.32% |
| Q3 2021 Q2Q % growth | 4.057M 38.04% | 5.423M | -1.366M | -25.19% |
| Q2 2021 Q2Q % growth | 3.285M -70.79% | 2.117M | 1.168M | 55.17% |
| Q1 2021 Q2Q % growth | 15.633M 17.89% | 6.596M | 9.037M | 137.01% |
| Q4 2020 Q2Q % growth | 1.877M | 3.893M | -2.016M | -51.79% |
| Q3 2020 Q2Q % growth | 2.939M | 9.99M | -7.051M | -70.58% |
| Q2 2020 Q2Q % growth | 11.246M | 7.918M | 3.328M | 42.03% |
| Q1 2020 Q2Q % growth | 13.261M | 9.017M | 4.244M | 47.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -11.66% | 0% | -7.59% |
| Revenue | N/A | N/A | N/A | N/A |